{"id":"https://openalex.org/A5029955834","orcid":"https://orcid.org/0009-0003-3059-3652","observed_orcids":["https://orcid.org/0009-0003-3059-3652"],"display_name":"Tracey Hammett","raw_author_names":["T. Hammett","Tracey C Hammett","Tracey Hammett"],"full_name":"Tracey Hammett","works_count":26,"cited_by_count":716,"summary_stats":{"2yr_mean_citedness":3.0,"h_index":6,"i10_index":4},"ids":{"openalex":"https://openalex.org/A5029955834","orcid":"https://orcid.org/0009-0003-3059-3652","observed_orcids":["https://orcid.org/0009-0003-3059-3652"]},"affiliations":[{"institution":{"id":"https://openalex.org/I105036370","ror":"https://ror.org/04r9x1a08","display_name":"AstraZeneca (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},"years":[2014,2008]},{"institution":{"id":"https://openalex.org/I4210100810","ror":"https://ror.org/014t21j89","display_name":"Sarah Cannon","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},"years":[2022,2021]},{"institution":{"id":"https://openalex.org/I4405267753","ror":"https://ror.org/046dw9c33","display_name":"iOnctura SA (Switzerland)","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]},"years":[2026,2025,2024,2023,2022]}],"last_known_institutions":[{"id":"https://openalex.org/I4405267753","ror":"https://ror.org/046dw9c33","display_name":"iOnctura SA (Switzerland)","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":10,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","count":10,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","count":9,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","count":7,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","count":6,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","value":8.01e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","value":5.56e-05,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","value":4.65e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","value":3.81e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","value":2.24e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9291728734970093},{"id":"502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","score":0.6199632883071899},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.5975000262260437},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.5802000164985657},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.541816771030426}],"counts_by_year":[{"year":2008,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":8},{"year":2013,"works_count":0,"oa_works_count":0,"cited_by_count":8},{"year":2014,"works_count":1,"oa_works_count":0,"cited_by_count":16},{"year":2015,"works_count":1,"oa_works_count":1,"cited_by_count":12},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":66},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":80},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":99},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":89},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":59},{"year":2021,"works_count":1,"oa_works_count":1,"cited_by_count":64},{"year":2022,"works_count":3,"oa_works_count":2,"cited_by_count":42},{"year":2023,"works_count":6,"oa_works_count":4,"cited_by_count":47},{"year":2024,"works_count":5,"oa_works_count":5,"cited_by_count":36},{"year":2025,"works_count":3,"oa_works_count":0,"cited_by_count":34},{"year":2026,"works_count":5,"oa_works_count":5,"cited_by_count":45}],"display_name_alternatives":["T. Hammett","Tracey C Hammett","Tracey Hammett"],"block_key":"t hammett","works_api_url":"https://api.openalex.org/works?filter=author.id:A5029955834","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5029955834","updated_date":"2026-11-12T13:17:38","created_date":"2016-06-24T00:00:00"}